Genes associated with Parkinson syndrome
暂无分享,去创建一个
Saskia Biskup | Thomas Gasser | Andreas Kupsch | Heinz Reichmann | Ullrich Wüllner | Peter Riederer | A. Kupsch | H. Reichmann | P. Riederer | M. Gerlach | P. Vieregge | T. Gasser | U. Wüllner | S. Biskup | Manfred Gerlach | Peter Vieregge
[1] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[2] M. Beal,et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.
[3] C. Ross,et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. , 2001, Human molecular genetics.
[4] P. Emson,et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain , 2006, Annals of neurology.
[5] HOMAS,et al. ASSOCIATION BETWEEN EARLY-ONSET PARKINSON ’ S DISEASE AND MUTATIONS IN THE PARKIN GENE , 2000 .
[6] T. Foroud,et al. Genes influencing Parkinson disease onset , 2004, Neurology.
[7] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[8] J. Schulz,et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.
[9] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[10] J. Jankovic,et al. Mutations in NR4A2 associated with familial Parkinson disease , 2003, Nature Genetics.
[11] C. Stichel,et al. Parkin expression in the developing mouse. , 2004, Brain research. Developmental brain research.
[12] Leonidas Stefanis,et al. α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.
[13] F. Moreau,et al. Parkin and CASK/LIN-2 Associate via a PDZ-mediated Interaction and Are Co-localized in Lipid Rafts and Postsynaptic Densities in Brain* , 2002, The Journal of Biological Chemistry.
[14] S. Minoshima,et al. Parkin is associated with cellular vesicles , 2001, Journal of neurochemistry.
[15] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[16] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[17] Tianhong Pan,et al. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. , 2008, Brain : a journal of neurology.
[18] O. Vitolo,et al. Ubiquitin Hydrolase Uch-L1 Rescues β-Amyloid-Induced Decreases in Synaptic Function and Contextual Memory , 2006, Cell.
[19] W. Oertel,et al. Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients , 2005, Movement disorders : official journal of the Movement Disorder Society.
[20] Gaofeng Wang,et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. , 2008, American journal of human genetics.
[21] Janel O. Johnson,et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. , 2004, Archives of neurology.
[22] M. Farrer,et al. Genetic association study of synphilin-1 in idiopathic Parkinson's disease , 2008, BMC Medical Genetics.
[23] F. Gage,et al. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. , 1999, Development.
[24] Nicholas W Wood,et al. Parkin disease: a phenotypic study of a large case series. , 2003, Brain : a journal of neurology.
[25] D. Moore. Parkin: a multifaceted ubiquitin ligase. , 2006, Biochemical Society transactions.
[26] Michael L. Kramer,et al. Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.
[27] M. MacDonald,et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. , 2002, American journal of human genetics.
[28] E. Tolosa,et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.
[29] M. Beal,et al. Mice lacking alpha-synuclein are resistant to mitochondrial toxins , 2006, Neurobiology of Disease.
[30] C. Olanow,et al. Leucine‐rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutants , 2007, Journal of neurochemistry.
[31] C. Ross,et al. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.
[32] N. Zhang,et al. alpha-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis. , 2008, The Journal of biological chemistry.
[33] A. Singleton,et al. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. , 2008, Human molecular genetics.
[34] H. Nakayama,et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.
[35] C. Ross,et al. Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation , 2005, The Journal of Neuroscience.
[36] A. Singleton,et al. Genetics of Parkinson's disease and parkinsonism , 2006, Annals of neurology.
[37] M. Riparbelli,et al. The Drosophila parkin homologue is required for normal mitochondrial dynamics during spermiogenesis. , 2007, Developmental biology.
[38] Leonidas Stefanis,et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. , 2004, Science.
[39] A. Schapira. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. , 1999, The Lancet. Neurology.
[40] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[41] Naoki Hisamoto,et al. LRK-1, a C. elegans PARK8-Related Kinase, Regulates Axonal-Dendritic Polarity of SV Proteins , 2007, Current Biology.
[42] D. Hernandez,et al. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. , 2003, Human molecular genetics.
[43] Michael L. Kramer,et al. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[45] L. Salamonsen,et al. Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. , 2003, The Biochemical journal.
[46] V. Bader,et al. Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. , 2007, Human molecular genetics.
[47] Reidun Torp,et al. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. , 2005, Human molecular genetics.
[48] A. Bentivoglio,et al. PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.
[49] G. Tocchini-Valentini,et al. GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs , 2007, Proceedings of the National Academy of Sciences.
[50] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[51] K. Wada,et al. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation , 2006, Journal of Cell Science.
[52] E. Masliah,et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress. , 2000, The American journal of pathology.
[53] J. Growdon,et al. A haplotype at the PARK3 locus influences onset age for Parkinson’s disease , 2003, Neurology.
[54] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[55] N. Hattori,et al. Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease. , 2008, Archives of neurology.
[56] L. Greene,et al. Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death , 2001, The Journal of Neuroscience.
[57] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[58] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[59] Takayuki Harada,et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice , 1999, Nature Genetics.
[60] PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1 , 2007, PLoS biology.
[61] H. Shill,et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease , 2008, Neurology.
[62] S. Tsuji,et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1 , 2002, Annals of neurology.
[63] I. Tomlinson,et al. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'. , 2007, Human molecular genetics.
[64] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.
[65] P. Worley,et al. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions , 1999, Nature Genetics.
[66] Changan Jiang,et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.
[67] 琢 波田野. Leucine-rich repeat kinase 2 associates with lipid rafts , 2007 .
[68] E. Tan. Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease. , 2006, Annals of the Academy of Medicine, Singapore.
[69] D. Sulzer,et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.
[70] L. Rakić,et al. α-Synuclein is expressed in different tissues during human fetal development , 2007, Journal of Molecular Neuroscience.
[71] A. Durr,et al. The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson’s disease in European populations , 2005, Journal of Medical Genetics.
[72] J. Downward,et al. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1 , 2007, Nature Cell Biology.
[73] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[74] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[75] P. Worley,et al. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. , 1999, Nature genetics.
[76] N. Avadhani,et al. Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain* , 2008, Journal of Biological Chemistry.
[77] Kiran Madura,et al. Proteasome dysfunction in aged human α-synuclein transgenic mice , 2006, Neurobiology of Disease.
[78] C. Ross,et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. Noth,et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease , 2004, Neurology.
[80] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[81] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[82] B. Müller-Myhsok,et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.
[83] Robert E. Burke,et al. Pitx3 is required for development of substantia nigra dopaminergic neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[84] J. Aharon-Peretz,et al. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.
[85] K. Lim,et al. Role of the ubiquitin proteasome system in Parkinson's disease , 2007, BMC Biochemistry.
[86] Angela C. Poole,et al. The PINK1/Parkin pathway regulates mitochondrial morphology , 2008, Proceedings of the National Academy of Sciences.
[87] Yuliang Wu,et al. Direct binding of α‐actinin enhances TRPP3 channel activity , 2007 .
[88] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[89] M. Beal,et al. Parkinson's disease. , 2007, Human molecular genetics.
[90] S. Srinivasula,et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice , 2003, Nature.
[91] Miguel Ángel Martínez,et al. Genome-wide scan linkage analysis for Parkinson’s disease: the European genetic study of Parkinson’s disease , 2004, Journal of Medical Genetics.
[92] B J Hoffer,et al. Dopamine neuron agenesis in Nurr1-deficient mice. , 1997, Science.
[93] T. Mitsui,et al. Parkin enhances mitochondrial biogenesis in proliferating cells. , 2006, Human molecular genetics.
[94] G. Hannon,et al. A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.
[95] T. Dawson,et al. Dynamic and redundant regulation of LRRK2 and LRRK1 expression , 2007, BMC Neuroscience.
[96] T. Dawson,et al. Parkin functions as an E3-dependent ubiquitin-protein ligase and promotes the degradation of synaptic vesicle associated protein , 2000 .
[97] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[98] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[99] 靖子 波田野. Novel PINK1 mutations in early-onset parkinsonism , 2005 .
[100] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[101] N. Hattori,et al. LRRK2 regulates synaptic vesicle endocytosis. , 2008, Experimental cell research.
[102] E. Masliah,et al. α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress , 2000 .
[103] Jan Gründemann,et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.
[104] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[105] M. Farrer,et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. , 2007, Parkinsonism & related disorders.